Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Versago Vascular Access
AddedFeb 16, 2024
UpdatedJun 18, 2026
Versago Vascular Access

Versago Vascular Access

Seed

Versago, a Massachusetts-based software company, innovates medical devices for enhanced vascular access in hemodialysis and oncology.

HQ
West Bridgewater, MA, US
Founded
2015
Overview
Compare
Fundraising
Employees

Versago Vascular Access, based in West Bridgewater, Massachusetts, focuses on innovating medical devices to enhance vascular access for hemodialysis and oncology patients. The company develops unique vascular access ports and associated devices, facilitating efficient and reliable access for treatments like chemotherapy and tumor imaging.

Versago's technology significantly improves patient care by providing a direct and dependable pipeline into the vasculature. Its products are widely used in power injection settings, contributing to better treatment outcomes and patient experiences.

Versago Vascular Access - Similar Companies

Access Vascular logo

Access Vascular

Hemova Medical logo

Hemova Medical

Bluegrass Vascular Technologies logo

Bluegrass Vascular Technologies

Vasca logo

Vasca

I-V Access Technology logo

I-V Access Technology

ivatinc.com

VascuLogic logo

VascuLogic

Traverse Vascular logo

Traverse Vascular

Cross Vascular logo

Cross Vascular

AccuVein logo

AccuVein

accuvein.com

Forge Medical logo

Forge Medical

forgemedical.com

Vascular Designs logo

Vascular Designs

Vascular Therapies logo

Vascular Therapies

vasculartx.com

VenoStent logo

VenoStent

venostent.com

Voyager Biomedical logo

Voyager Biomedical

Baton Rouge Vascular Access logo

Baton Rouge Vascular Access

Versago Vascular Access - Quick Facts

Who are Versago Vascular Access' competitors?

Companies similar to Versago Vascular Access include Access Vascular, Hemova Medical, Bluegrass Vascular Technologies and Vasca.

When was Versago Vascular Access founded?

Versago Vascular Access was founded in 2015.

Where is Versago Vascular Access' headquarters located?

Versago Vascular Access' headquarters is located in West Bridgewater, MA, US.

When was Versago Vascular Access' last funding round?

Versago Vascular Access' most recent funding round was for $1.6M (USD) in February 2016.

How much has Versago Vascular Access raised to-date?

As of Feb 24, 2016, Versago Vascular Access has raised a total of $1.6M (USD).

How many employees does Versago Vascular Access have?

Versago Vascular Access has 6 employees as of Feb 5, 2024.

Versago Vascular Access - Classification

Ownership
  • Private
Technology
  • Biotech
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Hardware
  • Software
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software